Caption Management’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-60,000
Closed -$3.68M 1980
2025
Q3
$3.68M Buy
60,000
+30,000
+100% +$1.56M 0.03% 600
2025
Q2
$1.47M Buy
+30,000
New +$1.42M 0.02% 816
2025
Q1
Sell
-79,600
Closed -$3.59M 1938
2024
Q4
$3.59M Buy
+79,600
New +$3.41M 0.03% 483
2024
Q3
Sell
-30,000
Closed -$917K 1530
2024
Q2
$917K Hold
30,000
0.01% 685
2024
Q1
$873K Sell
30,000
-30,000
-50% -$840K 0.01% 768
2023
Q4
$1.65M Buy
+60,000
New +$1.37M 0.02% 669
2022
Q4
Sell
-50,000
Closed -$2.51M 1633
2022
Q3
$2.51M Buy
50,000
+20,000
+67% +$980K 0.03% 561
2022
Q2
$1.2M Buy
+30,000
New +$1.05M 0.02% 821
2022
Q1
Sell
-30,000
Closed -$1.2M 1843
2021
Q4
$1.2M Hold
30,000
0.01% 977
2021
Q3
$1.12M Sell
30,000
-60,000
-67% -$2.46M 0.01% 990
2021
Q2
$3.81M Buy
+90,000
New +$3.86M 0.05% 451
2020
Q4
Sell
-30,000
Closed -$1.4M 1201
2020
Q3
$1.4M Buy
+30,000
New +$1.48M 0.03% 536
2020
Q1
Sell
-30,000
Closed -$1.44M 1031
2019
Q4
$1.44M Hold
30,000
0.05% 427
2019
Q3
$1.01M Buy
30,000
+12,000
+67% +$522K 0.05% 376
2019
Q2
$811K Sell
18,000
-18,000
-50% -$711K 0.04% 404
2019
Q1
$1.35M Sell
36,000
-14,000
-28% -$470K 0.07% 295
2018
Q4
$1.72M Buy
+50,000
New +$1.8M 0.14% 202
2018
Q3
Sell
-35,000
Closed -$1.18M 622
2018
Q2
$1.18M Buy
+35,000
New +$1.09M 0.09% 235

Other funds holding PTCT

Caption Management's PTCT Position: Q3 2024 in Review

Caption Management sold out of PTC Therapeutics (PTCT) in Q3 2024, closing a stake of 6,300 shares — an estimated $193K sold.

Caption Management first reported a position in PTCT in Q2 2018 and held it in 11 quarters. The position peaked at $5.24M in Q4 2019. 202 funds tracked by Wall St. Rank hold PTCT as of Q3 2024.

  • Caption Management reported no remaining PTC Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Caption Management sold 6,300 PTC Therapeutics shares in Q3 2024, an estimated $193K.
  • Caption Management first reported a position in PTC Therapeutics in Q2 2018 and held it in 11 quarters.
  • Caption Management's PTC Therapeutics position peaked at $5.24M in Q4 2019.
  • 202 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2024.

Based on Caption Management's 13F filing for Q3 2024, filed 14 Nov 2024.